Cocrystallization of gliclazide with improved physicochemical properties

被引:0
作者
Shivarani Eesam
Jaswanth S. Bhandaru
Raghuram Rao Akkinepally
Ravi Kumar Bobbala
机构
[1] Kakatiya University,Department of Medicinal Chemistry, University College of Pharmaceutical Sciences
[2] Piramal Pharma Limited,undefined
来源
Future Journal of Pharmaceutical Sciences | / 7卷
关键词
Gliclazide; Cocrystallization; Solubility; In vitro dissolution; Bioavailability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 205 条
[21]  
Ten BMS(2011)From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids Chem Rev 101 1629-490
[22]  
Storm G(2016)Multi drug co-crytals: towards the development of effective therapeutic hybrids Drug Discov Today 21 481-111
[23]  
Medema JP(2007)Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal Acta Crystallogr C 63 12931-4
[24]  
Schiffelers RM(2013)On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin Med Chem Commun 4 101-1179
[25]  
Kessler JH(2018)Continuous manufacturing of co-crystals: challenges and prospects Drug Deliv Transl Res 19 1-250
[26]  
Hu L(2015)Characterization and solubility studies of pharmaceutical cocrystals of eprosartan mesylate cocrystals Cryst Growth Des 15 1173-2283
[27]  
Jia Y(2020)Solubility enhancement of carvedilol using drug–drug cocrystallization with hydrochlorothiazide Futur J Pharm Sci 6 77-563
[28]  
Niu F(2017)Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization Drug Dev Ind Pharm 44 243-53
[29]  
Zheng J(2016)Novel cocrystals of gliclazide: characterization and evaluation CrystEngComm 18 2275-2417
[30]  
Yang X(2017)Supramolecular cocrystals of gliclazide: synthesis, characterization and evaluation Pharm Res 34 552-3581